Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy

Abstract excerpt

Abstract: Hypophosphatasia (HPP) is a multi-systemic metabolic disorder caused by loss-of-function mutations in the ALPL gene that encodes the mineralization-associated enzyme, tissue-nonspecific alkaline phosphatase (TNSALP). HPP is characterized by defective bone and dental mineralization, leading to skeletal abnormalities with complications resulting in significant morbidity and mortality. Management of HPP...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alkaline Phosphatase Research Studies
• Share to Biochemical and Molecular Research
• Share to Heterotopic Ossification and Related Conditions